Dr. Haffar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4700 N Galloway Ave
Mesquite, TX 75150Phone+1 972-686-6411Fax+1 972-613-8558
Education & Training
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2007- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2002 - 2005
Texas Tech University Health Sciences Center School of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2005 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 16
- Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 02
- A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
